Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Opportunistic Infections

ribavirin has been researched along with Opportunistic Infections in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19902 (10.53)18.7374
1990's1 (5.26)18.2507
2000's6 (31.58)29.6817
2010's10 (52.63)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douthwaite, S; Evans, TJ; Hilton, R1
Casado, JL; Dronda, F; Hermida, JM; Moreno, A; Moreno, S; Navas, E; Pérez-Elías, MJ; Quereda, C; Royuela, A; Serrano-Villar, S1
Bahra, M; Hofmann, J; Klein, F; Neuhaus, P; Neuhaus, R; Rudolph, B1
Choi, YW; Huh, KC; Kang, YW; Kim, SM; Kim, YS; Lee, KO; Lee, TH1
Huarte, MP; Lacruz, B; Quispe, I; Tiberio, G; Torroba, L1
Abravanel, F; Alric, L; Anty, R; Bureau, C; Gérolami, R; Guillaume, M; Izopet, J; Kamar, N; Nana, J; Pariente, A; Péron, JM; Renou, C; Robic, MA; Vinel, JP1
Bani-Sadr, F; Cacoub, P; Carrat, F; Driss, H; Goderel, I; Lapidus, N; Lunel-Fabiani, F; Morand, P; Perronne, C; Pol, S; Rosenthal, E; Simon, A1
Cornberg, M; Hadem, J; Hauptmann, C; Manns, MP; Süttmann, U; Wedemeyer, H1
Erdman, DD; Maziarz, RT; Meyers, G; Peret, TC; Post, M; Slater, S; Sridharan, P; Taplitz, RA1
González, S; Velasco, J1
Kang, P; Sun, LJ; Yan, BZ; Yu, JW; Zhao, YH1
Aichelburg, MC; Breitenecker, F; Ferenci, P; Heil, PM; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Scherzer, TM; Schuster, C1
Abe, S; Kasai, M; Kitaori, K; Kodera, Y; Miyamura, K; Oba, T; Sasaki, T; Terakura, S1
Fujimi, A; Hirayama, Y; Iyama, S; Kohda, K; Kuribayasi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sakamaki, S; Sato, T1
Manz, M; Steuerwald, M1
Boven, K; de Graeff-Meeder, B; Geelen, SP; Kuis, W; van Dijken, PJ; Wulffraat, NM1
Boeckh, M; Gooley, T; Nichols, WG1
Balfour, HH; Dehner, LP; Englund, JA; Jordan, MC; Sullivan, CJ; Vercellotti, GM1
Bubley, G; Crumpacker, C; Finberg, R; Heagy, W; Hussey, S; Lee, TH; Lucey, D; McLane, MF; Monroe, JE; Schnipper, L1

Trials

1 trial(s) available for ribavirin and Opportunistic Infections

ArticleYear
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
    AIDS (London, England), 2008, Jul-11, Volume: 22, Issue:11

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opportunistic Infections; Recombinant Proteins; Ribavirin

2008

Other Studies

18 other study(ies) available for ribavirin and Opportunistic Infections

ArticleYear
Treating chronic hepatitis E: when is enough enough?
    BMJ case reports, 2018, Feb-01, Volume: 2018

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Feces; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Ribavirin; Treatment Outcome; Viral Load; Virus Shedding

2018
Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:3

    Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Middle Aged; Neutropenia; Opportunistic Infections; Prospective Studies; Ribavirin; Risk Assessment

2013
Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13, Issue:3

    Topics: Antiviral Agents; Biopsy; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Ribavirin; Time Factors; Treatment Outcome; Viral Load

2015
Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin.
    The Korean journal of internal medicine, 2014, Volume: 29, Issue:3

    Topics: Antifungal Agents; Antiviral Agents; Cryptococcus neoformans; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome

2014
[Helicobacter cinaedi-associated bacteremia in hepatitis C patient under triple therapy].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:2

    Topics: Antiviral Agents; Bacteremia; Drug Therapy, Combination; Helicobacter; Helicobacter Infections; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opportunistic Infections; Recombinant Proteins; Ribavirin

2015
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Antiviral Agents; Drug Administration Schedule; Female; France; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Recurrence; Remission Induction; Ribavirin; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Viral Load

2016
Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.
    Zeitschrift fur Gastroenterologie, 2008, Volume: 46, Issue:9

    Topics: Adult; Antiviral Agents; Bacterial Proteins; Cefotaxime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Hearing Loss, Unilateral; Hepatitis C, Chronic; Humans; Infusions, Intravenous; Interferon Type I; Interferon-alpha; Male; Meningitis, Pneumococcal; Opportunistic Infections; Penicillin G; Pneumococcal Vaccines; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Splenectomy

2008
Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Disease Outbreaks; Female; Hematopoietic Stem Cell Transplantation; HN Protein; Humans; Immunocompromised Host; Infection Control; Male; Middle Aged; Molecular Epidemiology; Opportunistic Infections; Outpatient Clinics, Hospital; Parainfluenza Virus 3, Human; Respirovirus Infections; Ribavirin; Treatment Outcome

2010
[Tuberculous lymphadenitis after successful treatment of hepatitis C].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:8

    Topics: Adult; Antiviral Agents; Cytokines; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Opportunistic Infections; Pakistan; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tuberculosis, Lymph Node

2011
The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.
    European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:12

    Topics: Adult; Age Factors; Antiviral Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Opportunistic Infections; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors

2011
The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV.
    The Journal of infection, 2012, Volume: 65, Issue:2

    Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Bacterial Infections; CD4-Positive T-Lymphocytes; Female; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Interferons; Leukocyte Count; Male; Middle Aged; Neutrophils; Opportunistic Infections; Ribavirin

2012
Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation.
    Bone marrow transplantation, 2003, Volume: 32, Issue:11

    Topics: Adenoviridae Infections; Administration, Oral; Adult; Bone Marrow Transplantation; Cystitis; Humans; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin; Transplantation, Homologous

2003
[Successful treatment with oral ribavirin of adenovirus-associated hemophagocytic syndrome in a stem cell transplantation recipient].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:5

    Topics: Adenoviridae Infections; Administration, Oral; Anemia, Aplastic; Antiviral Agents; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Ribavirin; Treatment Outcome

2005
Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1

    Topics: Antiviral Agents; Cryptosporidiosis; Enterocolitis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin

2007
Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin.
    Transplantation, 1995, Mar-27, Volume: 59, Issue:6

    Topics: Adenoviridae Infections; Humans; Infant; Injections, Intravenous; Male; Opportunistic Infections; Pneumonia, Viral; Ribavirin; Severe Combined Immunodeficiency

1995
Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2001, Volume: 7 Suppl

    Topics: Clinical Trials as Topic; Communicable Disease Control; Community-Acquired Infections; Hematopoietic Stem Cell Transplantation; Humans; Opportunistic Infections; Paramyxoviridae Infections; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Risk Factors; Survival Rate

2001
Respiratory syncytial virus infection in immunocompromised adults.
    Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3

    Topics: Adult; Antigens, Viral; Cross Infection; Female; Humans; Immune Tolerance; Immunosuppression Therapy; Male; Middle Aged; Opportunistic Infections; Postoperative Complications; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Serologic Tests; Transplantation

1988
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and
    Annals of internal medicine, 1987, Volume: 107, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Drug Evaluation; Hematocrit; HIV; Humans; Lymphocyte Activation; Male; Opportunistic Infections; Ribavirin; Ribonucleosides

1987